What is AVL-3288 used for?

AVL-3288 is being researched for the treatment of schizophrenia and schizoaffective disorder.

Is AVL-3288 an approved medication?

No, AVL-3288 is currently a research compound in Phase 1 testing and is not yet approved for medical use.

What kind of drug is AVL-3288?

AVL-3288 is classified as a small molecule drug candidate.

What are the potential uses for AVL-3288?

Researchers are looking into how AVL-3288 might help people with psychotic disorders like schizophrenia.

What stage of testing is AVL-3288 in?

AVL-3288 is in the early stages of clinical development, specifically Phase 1.

Are there known side effects for AVL-3288?

There is no specific side effect data provided in the current research summary for AVL-3288.

Avl-3288 | CAS 917837-54-8 | VMAKIACTLSBBIY

Loading compound...

Experimental small molecule

AVL-3288 is an experimental small molecule currently being studied in early research stages. It is being investigated for its potential to treat conditions like schizophrenia and schizoaffective disorder.

How it worksAVL-3288 is a small molecule that interacts with various biological targets to potentially manage symptoms of psychotic disorders.

Used for

SchizophreniaSchizoaffective disorder

Conditions

SchizophreniaSchizoaffective disorder

Class

Small moleculeExperimental small moleculeCentral Nervous System

How to take

This drug is currently in a research phase (Phase 1) and is not yet approved for general use by regulatory agencies.

Talk to your doctor

Questions to ask

·Is AVL-3288 part of any current clinical trials?
·What are the potential risks of this experimental compound?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.

How to take

Talk to your doctor

Frequently asked questions (6)